Potential of peptides and phytochemicals in attenuating different phases of islet amyloid polypeptide fibrillation for type 2 diabetes management

Islet amyloid polypeptide (IAPP), or amylin, has been identified as a key factor in the development of type 2 diabetes (T2D). IAPP aggregates, which form amyloid fibrils, contribute to cytotoxicity of the pancreatic β-cells, resulting in loss of function and subsequent reduction in insulin productio...

Full description

Saved in:
Bibliographic Details
Main Authors: Raliat O. Abioye, Chibuike C. Udenigwe
Format: Article
Language:English
Published: Tsinghua University Press 2021-05-01
Series:Food Science and Human Wellness
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2213453021000264
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832557599123308544
author Raliat O. Abioye
Chibuike C. Udenigwe
author_facet Raliat O. Abioye
Chibuike C. Udenigwe
author_sort Raliat O. Abioye
collection DOAJ
description Islet amyloid polypeptide (IAPP), or amylin, has been identified as a key factor in the development of type 2 diabetes (T2D). IAPP aggregates, which form amyloid fibrils, contribute to cytotoxicity of the pancreatic β-cells, resulting in loss of function and subsequent reduction in insulin production. As a result, surviving β-cells overcompensate for this reduction of insulin production, further contributing to the loss of function because of increased stress, thus leading to insulin resistance. Endogenously, IAPP monomers function in a variety of roles; however, aggregation renders them non-functional. The use of naturally occurring compounds, including peptides and phytochemicals, has been explored as a way to mitigate or inhibit IAPP fibril formation. This review discusses the structure, endogenous roles and mechanism of IAPP fibril formation, recent advances on inhibitors of IAPP fibril formation, and new insights on the future development and application of food-derived inhibitors towards T2D management.
format Article
id doaj-art-bdd09441a2054fab96a1680c46c049a4
institution Kabale University
issn 2213-4530
language English
publishDate 2021-05-01
publisher Tsinghua University Press
record_format Article
series Food Science and Human Wellness
spelling doaj-art-bdd09441a2054fab96a1680c46c049a42025-02-03T04:08:07ZengTsinghua University PressFood Science and Human Wellness2213-45302021-05-01103259269Potential of peptides and phytochemicals in attenuating different phases of islet amyloid polypeptide fibrillation for type 2 diabetes managementRaliat O. Abioye0Chibuike C. Udenigwe1Department of Chemistry and Biomolecular Sciences, Faculty of Science, University of Ottawa, Ottawa, Ontario, K1N 6N5, CanadaDepartment of Chemistry and Biomolecular Sciences, Faculty of Science, University of Ottawa, Ottawa, Ontario, K1N 6N5, Canada; School of Nutrition Sciences, Faculty of Health Sciences, University of Ottawa, Ottawa, Ontario, K1H 8M5, Canada; Corresponding author. University Research Chair in Food Properties and Nutrient Bioavailability, School of Nutrition Sciences, Faculty of Health Sciences, University of Ottawa, Ottawa, Ontario, K1H 8M5, Canada.Islet amyloid polypeptide (IAPP), or amylin, has been identified as a key factor in the development of type 2 diabetes (T2D). IAPP aggregates, which form amyloid fibrils, contribute to cytotoxicity of the pancreatic β-cells, resulting in loss of function and subsequent reduction in insulin production. As a result, surviving β-cells overcompensate for this reduction of insulin production, further contributing to the loss of function because of increased stress, thus leading to insulin resistance. Endogenously, IAPP monomers function in a variety of roles; however, aggregation renders them non-functional. The use of naturally occurring compounds, including peptides and phytochemicals, has been explored as a way to mitigate or inhibit IAPP fibril formation. This review discusses the structure, endogenous roles and mechanism of IAPP fibril formation, recent advances on inhibitors of IAPP fibril formation, and new insights on the future development and application of food-derived inhibitors towards T2D management.http://www.sciencedirect.com/science/article/pii/S2213453021000264Islet amyloid polypeptideFibril formationDisaggregationBioactive peptidesPhytochemicals
spellingShingle Raliat O. Abioye
Chibuike C. Udenigwe
Potential of peptides and phytochemicals in attenuating different phases of islet amyloid polypeptide fibrillation for type 2 diabetes management
Food Science and Human Wellness
Islet amyloid polypeptide
Fibril formation
Disaggregation
Bioactive peptides
Phytochemicals
title Potential of peptides and phytochemicals in attenuating different phases of islet amyloid polypeptide fibrillation for type 2 diabetes management
title_full Potential of peptides and phytochemicals in attenuating different phases of islet amyloid polypeptide fibrillation for type 2 diabetes management
title_fullStr Potential of peptides and phytochemicals in attenuating different phases of islet amyloid polypeptide fibrillation for type 2 diabetes management
title_full_unstemmed Potential of peptides and phytochemicals in attenuating different phases of islet amyloid polypeptide fibrillation for type 2 diabetes management
title_short Potential of peptides and phytochemicals in attenuating different phases of islet amyloid polypeptide fibrillation for type 2 diabetes management
title_sort potential of peptides and phytochemicals in attenuating different phases of islet amyloid polypeptide fibrillation for type 2 diabetes management
topic Islet amyloid polypeptide
Fibril formation
Disaggregation
Bioactive peptides
Phytochemicals
url http://www.sciencedirect.com/science/article/pii/S2213453021000264
work_keys_str_mv AT raliatoabioye potentialofpeptidesandphytochemicalsinattenuatingdifferentphasesofisletamyloidpolypeptidefibrillationfortype2diabetesmanagement
AT chibuikecudenigwe potentialofpeptidesandphytochemicalsinattenuatingdifferentphasesofisletamyloidpolypeptidefibrillationfortype2diabetesmanagement